APA (7th ed.) Citation

Tokgöz, H. C., Kaymaz, C., Kültürsay, B., Tanyeri, S., Buluş, Ç., Sırma, D., . . . Tanboga, İ. H. (2026). Could We Maintain the Initial Efficacy of Triple Sequential Combination Therapies with Selexipag Against Progressive Deterioration Risk in Patients with Pulmonary Arterial Hypertension: Insights from a Single-Center Study? Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi, 30(4), 248. https://doi.org/10.14744/AnatolJCardiol.2025.5976

Chicago Style (17th ed.) Citation

Tokgöz, Hacer Ceren, et al. "Could We Maintain the Initial Efficacy of Triple Sequential Combination Therapies with Selexipag Against Progressive Deterioration Risk in Patients with Pulmonary Arterial Hypertension: Insights from a Single-Center Study?" Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi 30, no. 4 (2026): 248. https://doi.org/10.14744/AnatolJCardiol.2025.5976.

MLA (9th ed.) Citation

Tokgöz, Hacer Ceren, et al. "Could We Maintain the Initial Efficacy of Triple Sequential Combination Therapies with Selexipag Against Progressive Deterioration Risk in Patients with Pulmonary Arterial Hypertension: Insights from a Single-Center Study?" Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi, vol. 30, no. 4, 2026, p. 248, https://doi.org/10.14744/AnatolJCardiol.2025.5976.